Skip to main content

BRIEF-Eiger announces additional phase 2 clinical trial results

* Eiger announces additional phase 2 clinical trial results for lonafarnib at the international liver congress 2017
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.